Editorial Board
Guilan University of Medical Sciences, Iran
| Biography Dr. Masood Sepehrimanesh, (born September 18, 1985, Sabzevar, Iran) is an Iranian Biochemist.He obtained his DVM degree in 2009 and Ph.D. degree in 2014 from Shiraz University. Dr. Sepehrimanesh is nationally known for proteomics work on diseases and disorders. He served as the Assistant professor and Dean of Specialized Laboratory of Gastroenterohepatology Research Center, Shiraz University of MedicalSciences, Shiraz, Iran from April 2014 to May 2017 and then the Assistant Professor of Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht Iran until now. Helectures at different Persian Universities and his research has been covered in major scientific publications. He has also authored more than 70 publications in scientific journals ranging from Electrophoresis and the Hepatitis Monthly to Comparative Clinical Pathology, presents more than37 papers in international and national congresses and two Elsevier book chapters. Dr. Sepehrimanesh’ work has received widespread recognition and he is a Young Elite Sponsored by National Elite Foundation from 2014. He prefers team work and all of his papers have several authors with different experiences. His fields of interest include: Biomarker finding by proteomics techniques; EMF biology; Hepatology and gastrointestinal diseases; Animal modeling of DM, UC, OM and applying phytomedicine to them; Obesity prevention and treatment. His published articles are related to these subjects and he currently focuses on the role of autophagy in diseases and health. Research Interest
|  |
Iuliu Hatieganu University of Medicine and Pharmacy, Romania
| Biography Dr. Barbu received his PhD in medical sciences with the thesis “Surgery for chronic pancreatitis”, and he developed his surgical skills in several European centers (Paris, Hamburg, and Bergen). He had an academic training stage at the University Paris VI, and currently he is a professor of surgery at the “IuliuHatieganu” University of Medicine and Pharmacy in Cluj, working as a primary surgeon in the 4th Surgery Department of the University. He is the President of the Romanian Pancreatic Club, vice-president of the Romanian Society of Coloproctology, Councilor in the European Federation of the International Society for Digestive Surgery (EFISDS) and member in the general assembly of United European Gastroenterology (UEG) as EFISDS representative. His research focuses on pancreatitis and periampullary tumors.He was involved in several guidelines for acute pancreatitis (International Association of Pancreatology 2002, Romanian guidelines 2005), criteria for alcoholic pancreatitis 2006, and guidelines for inherited diseases of the pancreas 2012. As a surgeon, he’s interested in oncologic, laparoscopic and HPB surgery. As a teacher, he organized several international postgraduate surgical courses in collaboration with EFISDS, European Pancreatic Club (EPC), and European Digestive Surgery (EDS), most of them with the UEG support. Research Interest
|  |
D. Cotugno Hospital, Italy
| Biography Dr. Antonio Giorgio’s clinical and research activity is mainly focused on the ultrasound diagnostics in liver diseases and the ultrasound guided percutaneous treatment of HCC on cirrhosis, hydatid and simple liver cysts, abdominal abscesses and metastatic tumors of the liver and, more recently, intrahepatic cholangio carcinoma. He is author of more than 350 scientific publications in Italian and English, published on the most prestigious international journals. He is author of many chapters in texts prepared by other authors, in general about ultrasound diagnostics. He has received the following acknowledgements: He is Nominated as International Health Professional of the Year 2010 by the International Biographic Centre di Cambridge – England. He is cited in the famous volume published in 2009 Who's Who in Medicine and Healthcare, 2009-2010 published by Marquis Who's Who. Research Interest
|  |
University of Texas Medical Branch, USA
| Biography Dr. Jiande Chen received his graduate education at the Catholic University of Leuven in Belgium. While there he started his research on gastrointestinal motility with a group of internationally renowned investigators in the Department of Medicine. Upon completing his PhD in 1989, he moved to the United State where he accepted a faculty position at the University of Virginia, School of Medicine. In 1995, Dr. Chen moved to Baptist Medical Center of Oklahoma, where he established an Electrophysiology Laboratory and worked intensively on electrophysiology of the gut and gastrointestinal pacing. In June 1999, he joined the Division of Gastroenterology, Department of Internal Medicine at UTMB and is currently a Professor of Medicine. Dr. Chen served as the first President of the International Electrogastrography Society, has given over 180 invited lectures in various countries, served on committees of national and international conferences, published one book, over 310 peer-reviewed journal articles and book chapters, and over 400 conference papers and abstracts. His research has been supported by over 100 grants from the federal government, state, private foundations and industries. He has filed or awarded more than 20 patent applications. He is a fellow of the American College of Gastroenterology and a member of various professional societies in medicine and biomedical engineering. Research Interest
|  |
University of Texas Health Science Center , USA
| Biography Dr.Atilla Ertan earned his medical degree in 1963 from the Ankara University Medical School in Turkey. Following completion of his fellowship in Gastroenterology at the Hospital of the University of Pennsylvania in 1971, he was professor of medicine at the Tulane University School of Medicine in New Orleans from 1980-90 where he was named Chief of the Gastroenterology Section from 1984-90 and Interim Chairman of Medicine Department from 1988-90. Then, he was Chief of the Gastroenterology Section at the Methodist Hospital/ Baylor College of Medicine (BCM) from 1990 to 2001. He is a Clinical Professor of Medicine at both BCM as well as Weill-Cornell Medical College. He is now professor at the University of Texas Health Science Center and Director of the Ertan Digestive Disease Center and Gastroenterology Center of Excellence at the Memorial Hermann Hospital-Texas Medical Center.Dr. Ertan has achieved national and international recognition as an outstanding clinical scientist, educator, researcher, and administrator in the field of gastroenterology. He has published over 160 articles in peer review journals, book chapters, books, and has received numerous awards and honors. Research Interest
|  |
Tulane Abdominal Transplant Institute , USA
| Biography Dr. Joseph Buell is Director of the Tulane Abdominal Transplant Institute at Tulane Medical Center. Dr. Buell specializes in liver, kidney and pancreas transplantation and hepatobiliary surgery, as well as minimally invasive liver surgery. He is a clinically active surgical oncologist and transplant surgeon. Previously, he was an intramural investigator at the NIH, Surgery Branch, working in the metabolism section and in conjunction with the Pharmacology Branch. During this time, he studied the mechanism and the ability to modify DNA injuries from cisplatin. Over the last fifteen years, he has worked with and developed several multiple ablation devices. After extensive experience with cryoablation, radiofrequency ablation, microwave ablation and most recently irreversible electroporation, he identified a significant incidence of late recurrence associated with incomplete ablations. These observations evolved from his clinical experience with over 1000 liver tumor patients and through immunohistochemistry analysis and TUNNEL assays on transplant explant specimens. Hepatocellular cancer is the third leading cause of cancer-related mortality worldwide and a leading indication for liver transplantation. Hepatocellular cancer in the setting of liver failure patients has been the most challenging cancer to manage. This disease has been a focus for Dr. Buell’s career for twenty years. He is dedicated to identifying, refining and pioneering new technologies for the treatment of this dramatically rising malignancy. Research Interest
|  |
University of Texas Medical Branch, USA
| Biography Dr. Andrea Duchini is currently the Director of Liver Transplantation in the Division of Gastroenterology and Hepatology, Department of Internal Medicine at The University of Texas Medical Branch (UTMB) in Galveston, TX. He is an Associate Professor of Medicine and Surgery. He also serves as UNOS Primary Physician for the Small Bowel Transplant Program. Dr. Duchini received his MD degree with honors in 1988 from the University of Florence, School of Medicine, Italy, where he also completed a Post-Graduate Program in Hepatology. He completed his Internal Medicine Residency at Baylor College of Medicine, Houston, Texas and his Gastroenterology Fellowship at Scripps Clinic and Research Foundation in La Jolla, California. He subsequently served as faculty at Baylor College of Medicine until 2009 as Assistant Professor of medicine and surgery. Dr. Duchini became a Fellow with the American College of Physicians in 2009 and is a member of the Texas Society of Gastrointestinal Endoscopy (TSGE), Texas Transplant Society (TTS), International Liver Transplant Society (ILTS), and the American Association for the Study of Liver Diseases (AASLD). He serves on several committees including the UTMB transplant board. Research Interest
|  |
Joan C. Edward School of Medicine , USA
| Biography Dr. Nihar Shah completed his medical training at the Smt.N.H.L.Municipal Medical College, Ahmedabad, India. Upon completition of his medical degree, he relocated to the United States and completed his Internal Medicine Residency, Gastroenterology and Hepatology Fellowship at Seton hall University School of health and Medical Sciences, NJ. He currently serves as an Assistant Professor, Section of Gastroenterology, in the Department of Medicine at Joan C. Edward School of Medicine, Marshall University where he serves an integral role in training medical students and residents in the fields of Gastroenterology and Hepatology. He was awarded Certificate of achievement in endoscopy education by American Society of Gastrointestinal Endoscopy in 2015 and was also elected as a fellow of American College of Physicians. Research Interest * Endoscopic treatment of Gastroesophageal Reflux Disease * Endoscopic Bariatrics * Quality improvement for colonoscopy |  |
Albert Einstein College of Medicine, USA
| Biography Dr. Xintao Wang received his Ph. D. in biochemistry from Rome University “La Sapienza” in Italy. He worked to study the structure and functions of copper proteins in University of Quebec at Montreal in Canada for three years. He jointed Albert Einstein College of Medicine in 1998 and focused on the study of potassium channel regulation by PKCz phosphorylation. Currently, he works in the Marion Bessin Liver Research Center of Albert Einstein College of Medicine to study the molecular mechanisms for the motility regulation of endocytic vesicles isolated from hypatocytes. Research Interest Dr. Xintao Wang's main research interest is to identify and characterize the PKCz target on ntcp-containing endocytic vesicles. |  |
Geneva University Hospitals, Switzerland
| Biography Dr. Catherine M Pastor received her MD in 1989 and her PhD on "The modifications of hepatic circulation and functions during sepsis: role of nitric oxide"in 1995 at the University of Paris V in France.Between1992 and 1994, she studied the role of hepatic nitric oxide in the regulation and functions of the liver in the Department of Surgery at the University Hospital of Pittsburgh in the US. Since then, she has been appointed director of a research laboratory at the University Hospital of Geneva in Switzerland. In 2013, she was nominated honorary Professor at the University of Medicine Paris-Diderot in France. Research Interest
|  |
Byelorussian Medical Academy, Belarus
| Biography Dr. Yury Marakhouski has completed his PhD (Endocrinology and Phathophysiology) from Radiation Endocrinology Laboratory of Byelorussian Academy of Sciences, and his MD (Internal Medicine) from Central Moscow Gastroenterology Institute, Russia. He approved as Professor of Clinical Medicine in 2005 year by the Higher Certification Commission of the Council of Ministers of the Republic of Belarus. He is head of the Department Gastroenterology and Nutrition of the Byelorussian Medical Academy of Postgraduate Education. He has published more than 30 papers in reputed journals and serving as a member of the editorial board of several reputed journals (predominantly in Russia and Belarus). His Current Position is Head of Department of Gastroenterology and Nutrition, Byelorussian Medical Academy Postgraduate Education (BelMAPE).He is principal investigator on numerous clinical (18) and preclinical (6) studies and has been involved in the study of many medication including mesalazine, amino acids, anti-TNF. Research Interest Dr. Yury Marakhouski research interests includes "Assessment interaction between inflammation, fibrosis, tissue reconstruction and nutrition intolerance at the gut pathophysiology and management diseases associated with such pathological conditions". |  |
Taif University, Saudi Arabia
| Biography Dr. Bilal O Al-Jiffry completed his residency in general surgery at King Faisal specialist hospital, Riyadh in 1998. Then did his PhD and Hepato-biliary fellow-ship and Live Tx in the university of Adelaide, Australia in 2001. This was followed by another year working with Professor Joseph Lau for another fellow ship as a senior lecturer in the Chinese University of Hong Kong, Hong Kong in 2002. In January 2003 he was appointed consultant HPB and Liver Tx in the National Guard Hospital, Riyadh till 2006, were he moved to the Military hospital in Taif as the Director of Surgery till 2010. From that time till now he is the director of surgery at Taif University while holding his post in the Military hospital as senior HPB consultant. He has over 40 invited lectures in HPB and liver Tx with four books in many aspects of HPB surgery. Currently he is a member of the executive Board of the Saudi Surgical Society and the editor and founder of the Saudi Surgical Journal. He also reviews for a few other journals in the surgical aspects and HPB surgery. Research Interest
|  |
University of Szeged, Hungary
| Biography Dr. Laszlo Czako received his medical degree from the Albert Szent-Gyorgyi Medical University in 1990, and health economist degree from Attila Jozsef University in 1999 in Szeged, Hungary. He is board certified in internal medicine, gastroenterology and diabetology. He is extensively trained in all aspects of gastroenterology in several leading endoscopic centers (Madrid, Amsterdam, Barcelona, Hamburg, Tokyo, and Vienna). He received his Ph.D. degree in 1999 and earned habilitation in 2005. He is a member of the editorial boards and an associate editor-in-chief of several gastrointestinal international journals. He wrote more than 100 full papers (independent citations: 932, Hirsch index: 22) in peer-reviewed international journals and 12 book chapters. He is currently a clinical professor for the First Department of Medicine, University of Szeged and involves in lecturing on gastrointestinal diseases and training the fellows on various endoscopic procedures. His main clinical interests include pancreatobiliary diseases (differential diagnosis, staging, treatment) including pancreatitis, pancreatic cancer, cholangiocarcinoma; advanced interventional endoscopy techniques including endoscopic ultrasonography, endoscopic retrograde cholangiopancreatography, and endoscopic mucosal resection. Research Interest
|  |
Aristoteleion University of Thessaloniki, Greece
| Biography Dr. Georgios Tsoulfas received his medical degree from Brown University School of Medicine and completed his general surgery residency at the University of Iowa Hospitals and Clinics, as well as a transplant research fellowship at the Starzl Transplant Institute at the University of Pittsburgh. He then completed a two-year transplantation surgery fellowship at the Massachusetts General Hospital, Harvard Medical School and then joined the Division of Solid Organ Transplantation and Hepatobiliary Surgery at the University of Rochester Medical Center as an Assistant Professor of Surgery. He has currently moved back to Greece, where he is an Assistant Professor of Surgery at the Aristoteleion University of Thessaloniki. He has published over 70 papers in peer-reviewed Journals and in PubMed, as well as 17 book chapters. He is a reviewer for 15 International Journal and on the Editorial Board of several others. The recipient of awards such as the Edward E. Mason award for excellence in patient care and education.He is a member of multiple committees, including the International Relations Committee of the American Hepatico PancreaticoBiliary Association (AHPBA). He is currently the president of the Greek Chapter of the International College of Surgeons, as well as European Federation Secretary of the International College of Surgeons and a member of the International Executive Council and the Executive Committee of the ICS. Research Interest Dr. Georgios Tsoulfas research interests include primary and metastatic hepatic malignancies and their multimodal management. |  |
University of Oklahoma Health Sciences Center, Oklahoma, USA
| Biography Dr. Parthasarathy Chandrakesan has a broad background in Stem cell biology, Cancer marker characterization and therapeutics, Gastroenterology and Endocrinology with extensive training and experience in molecular and cellular biology and animal models relevant to the background knowledge. As a fellow (research) at the University of Oklahoma Health Sciences Center, he carried out research investigating the role of NF-kB/b-catenin/Notch signaling during intestinal crypt hyperplasia and neoplasia. He extended his research to explore the novelty hiding behind the core of bacterial infection induced EMT and tumorigenesis in the colon. His major research focus is on Regenerative medicine utilizing the stem cells for clonal expansion culture and experimental therapeutics using novel nanotechnology and ADC combination therapies for cancer treatment. He is honorable member of the American Gastroenterological Association and member of the Society of Reproductive Biology and Comparative Endocrinology. Research Interest
|  |
Palmi Hospital, Italy
| Biography Dr. Francesco Loria, graduated in Medicine from Messina University (Italy), specialization in Radiology at Genoa (Italy) University and in Radiation Oncology at Messina (Italy) University. He was accredited graduation and specializations in Switzerland. He was the winner at European Congress of Radiology in Vienna 1995. He has authored 127 publications about conventional X-Rays, US-CEUS, CT and MR in national and international specialist reviews like Radiologia Medica, Radiology, American Journal of Radiology, British Journal of Radiology, European Radiology, Radiology and Oncology, Anticancer Research, Updates in Surgery and more. He is author of 50 reports at national and international congress. Research Interest
|  |
The Royal Infirmary of Edinburgh, UK
| Biography Dr. Anastasios Koulaouzidis obtained his MD from the Medical School of the Aristotle University of Thessaloniki (Greece), in 1995. Since 2009, he has been an Associate Specialist in Gastroenterology with the Royal Infirmary of Edinburgh, Scotland, UK. He is the co-author of three book chapters and more than 90 PubMed articles.His research interests include clinical applications of capsule endoscopy, concept development, artificial neural networks application, quality improvement and software diagnostics in capsule endoscopy. Other specialty interests include anaemia, faecal calprotectin, microscopic colitis, soluble transferrin receptors and conventional endoscopy. He is member of the editorial and/or advisory board of several specialty journals and the Editor-in-Chief of the –recently launched– Global Journal of Gastroenterology & Hepatology. Dr Koulaouzidis was awarded the Given®Imaging-ESGE Research grant 2011, one of innovation Initiative-University of Edinburgh grants in 2011 and one of the ESGE visiting Fellow postgraduate grants (2010). Research Interest
| .jpg) |
Ankara University Medical School Department of Nuclear Medicine, Turkey
| Biography Dr. Soydal received her M. D. in Medical Faculty of Ankara University in Turkey. She had worked, as a Nuclear Medicine Resident in Department of Nuclear Medicine Ankara University Medical Schoold and she has become a Nuclear Medicine Consultant in 2012. She had authored many peer-reviewed articles which were published in many international journals. Research Interest
|  |
Thomas Jefferson University Hospital, USA
| Biography Dr. Halegoua-De Marzio is currently a senior fellow in Transplant Hepatology at Thomas Jefferson University Hospital. Dr. Halegoua-De Marzio attended medical school at Temple University School of Medicine were she was honor with induction into AOA. She completed her internship, Internal Medicine residency and Gastroenterology and Hepatology fellowship at Thomas Jefferson University Hospital. Her research interest include drug induced liver injury, nonalcoholic fatty liver disease and graduate medical education. Research Interest
|  |
Southern Research Institute, USA
| Biography Dr. Padmalayam obtained a Ph.D. in Molecular Biology and Genetics from Georgia State University (GSU) in Atlanta in 1996. She continued her postdoctoral work at the Division of Viral and Ricketssial Diseases at the CDC, conducting further investigations into the pathogenesis of bartonellae and their interactions with host cells during infection. In 2001, she joined Reddy US (RUS) Therapeutics, Inc., a drug discovery company based in Norcross, GA. While at RUS, her research focus shifted to metabolic diseases, and she identified a novel mitochondrial target gene that plays a key role in metabolic diseases such as type 2 diabetes, obesity, and cardiovascular disease. She joined Southern Research in August 2010 and currently serves in multiple roles, including Program Manager of the Strategic Initiatives Plan (SIP), an internal research funding program, and Head of the Assay Development/Lead Generation Laboratory. Her laboratory provides research support for various drug discovery programs at Southern Research which span a broad range of therapeutic areas such as oncology, infectious, neurodegenerative and metabolic diseases. She has authored numerous publications in peer-reviewed journals and holds three patent applications. Research Interest Dr. Padmalayam’s research interest includes identifying novel and druggable targets for obesity, diabetes and the metabolic syndrome. |  |
Baylor College of Medicine, Texas
| Biography Dr. Mittal received his medical training at Postgraduate Institute of Medical Education (PGIMER), one of the most prestigious medical institutes of India. Subsequently he moved to United States and completed his residency in Internal Medicine and fellowship in Gastroenterology at the University of Texas Medical Branch (UTMB) in Galveston. He also completed an advanced degree in clinical research and has been actively involved in clinical epidemiology research at UTMB. In July 2012, he joined the Division of Gastroenterology and Hepatology, at Baylor College of Medicine and is currently an Assistant Professor of Medicine. Dr Mittal has received numerous awards and grants in his carrier. He was awarded pilot research grants at UTMB; both grants funded studies of different aspects of liver disease (e.g. porphyria and ascites). Dr. Mittal clinical research has been recognized by several awards including the Comparative Effectiveness Research on Cancer in Texas (CERCIT) Scholar at UTMB, the American College of Gastroenterology Travel award in 2011, and the American Gastroenterological Association Travel Grant for outcomes research workshop in 2007. He recently received American College of Gastroenterology Clinical Research Award for studying effectiveness of treatment in chronic hepatitis B. Dr. Mittal has published numerous articles and abstracts given several presentations at national and international conferences. Research Interest
|  |
National Taiwan University Hospital, Taiwan
| Biography Dr. Chen is an attending physician and a principle investigator of department of medical research in National Taiwan University Hospital and an adjunct associate professor in the Graduate Institute of Molecular and Comparative Pathobiology in National Taiwan University. He earned his MD degree in 1995 at the National Taiwan University in Taipei, Taiwan and completed a residency in Internal Medicine and Family Medicine at National Taiwan University Hospital in 2001. Then, he moved to USA to receive laboratory training in drug discovery and cancer biology. He earned his PhD degree in 2005 at the department of medicinal chemistry, college of pharmacy, The Ohio State University, in Columbus, Ohio.His research centers on the molecular pharmacology and drug discovery in cancer. He has received several research awards, including the Young Investigator Award of National Science Council of Taiwan (Wu Da-Yu memorial award). Recently, his discovery of novel sorafenib derivatives has been selected as the first new drug project of Taiwan Supra Incubation Center (SIC). The Taiwan Government will support financially for the development of Dr. Chen's compound in clinical investigations of cancer treatment. Research Interest
|  |
Harvard Medical School, USA
| Biography Dr. Alireza Haghighi is a clinician scientist. He graduated from University of Oxford and is currently based at theDepartment of Genetics of Harvard Medical School and Brigham and Women’s Hospital. Research Interest Dr.Haghighi's research interests include clinical and genetic investigation of inherited diseases, using state of the art technologies such as high throughput genotyping and next generation sequencing. |  |
Shengjing Hospital of China Medical University, China
| Biography Dr. Lianjie Lin received her graduate education at the China Medical University in China and accepted a faculty position at Shengjing Hospital of China Medical University in 1998. She got a scholarship of Sasakawa and did research in the Gastroenterology Department of Tokyo University. In 2008, she became the associated professor in the Department of Gastroenterology, Department of Internal Medicine at Shengjing Hospital. Research Interest
|  |
University of Hong Kong, Hong Kong
| Biography Dr. Seto Wai Kay graduated from the University of Hong Kong in 2003 and received his Fellowship in Gastroenterology and Hepatology in 2010 from the Hong Kong College of Physicians. He is currently a Clinical Assistant Professor in the Department of Medicine, the University of Hong Kong, Hong Kong. He is also a Consultant in the Department of Medicine, HKU-Shenzhen Hospital, Shenzhen, China, aiming in establishing clinical services in Internal Medicine and Gastroenterology in Shenzhen. In 2012 he received his Doctor of Medicine from the University of Hong Kong and was also a visiting post-doctoral fellow in Baylor College of Medicine, Houston, Texas. In his young academic career, he has published more than 50 peer-reviewed articles, including several in high-impact peer-reviewed journals including Hepatology, Journal of Hepatology and Clinical Infectious Diseasesas first author, and is a frequent reviewer of 8 peer-reviewed journals in Gastroenterology and Hepatology. He has been awarded the Distinguished Research Paper Award for Young Investigator (2012 and 2013) and the Young Investigator Research Grant (2012), both from the Hong Kong College of Physicians. Research Interest
|  |
Guangzhou Medical University, China
| Biography Dr. Yang received his B.S. from the School of Gannan Medical College in JiangXi in 2003. He received his M.S. in 2006 and his Ph.D. in 2010 from Guangzhou Medical University in Guanghou China. In 2007, he joined Yu-Jui Yvonne Wan’s lab in University of Kansas Medical Center to study molecular biology of the liver cancer. After two years, he worked as postdoctoral fellow in Wan’s lab. In 2010, Dr. Yang was recruited by the Department of Gastroenterology of the Second Affiliated Hospital in Guangzhou Medical University. His studies focuse on the molecular mechanisms of HDACi antitumor effects and the pathophysiology of the liver with specific interests in understanding the mechanism underlying the development of metabolic syndromes, fatty liver, fibrosis, cirrhosis, and liver cancer. The goal is to identify potential therapeutic targets in the prevention and treatment of liver disease. Research Interest
|  |
Jikei University Daisan Hospital, Japan
| Biography Dr. Akiyoshi Kinoshita graduated from Jikei University School of Medicine in 1998. He worked as a medical intern and resident in Jikei University Hospital, Fuji City General Hospital, and Social Insurance Sakuragaoka General Hospital; currently, he works as an assistant professor and chief of the hospital ward in the Division of Gastroenterology/Department of Internal Medicine, the Jikei University Daisan Hospital. He obtained his doctorate in medicine in 2010 and is currently a councilor of the Japanese Society of Gastroenterology, Kanto Division. Till date, he has published research papers in nine international peer review journals, and reviewed nine international peer review journals. Moreover, he works as an Editorial Board Member of the International Journal of Statistics in Medical Research, JSM Gastroenterology and Hepatology, Journal of Translational Medicine & Epidemiology, World Research Journal of Palliative Care & Medicine. He specializes in the diagnosis and treatment of gastrointestinal cancer including hepatocellular cancer. Research Interest
|  |
University Hospital P. Giaccone in Palermo, Italy
| Biography Dr. Fabio Salvatore Macaluso is currently a trainee fellow in Gastroenterology at University Hospital “P. Giaccone” in Palermo, Italy. He attended the medical school at University School of Medicine in Palermo, where he graduated. He is author of several scientific papers indexed on PubMed and published on high impact factor journals, and he also served as reviewer for international journals. Research Interest
|  |
Roswell Park Cancer Institute , USA
| Biography Dr. Amanpal Singh completed his medical training at the All India Institute of Medical Sciences in New Delhi, India. Upon conferral of his medical degree, he relocated to the United States and earned a Master of Science in Epidemiology from Harvard School of Public Health. Subsequently, he completed his Internal Medicine Residency, Gastroenterology and Hepatology Fellowship at the University of Texas Medical Branch. More recently, he completed an Advanced Therapeutic Endoscopy Fellowship at the University of Texas MD Anderson Cancer Center. He currently serves as an Assistant Professor, Division of Gastroenterology, in the Department of Medicine at Roswell Park Cancer Institute where he serves an integral role in training fellows, residents and medical students in the fields of Gastroenterology and Endoscopy. He has been associated with the Center for Comparative Effectiveness and Cancer Outcomes (CECCO), since its inception in 2009. He was awarded 2013 American College of Gastroenterology Astra Zeneca Fellow Award for his research. His research has been selected multiple times for American Society of Gastrointestinal Endoscopy’s Presidential Plenary and American Gastroenterology Association’s Distinguished Plenary Presentations. Research Interest
|  |
National Institute of Science Education and Research , India
| Biography Dr. Asima Bhattacharyya is a scientist at National Institute of Science Education and Research (NISER), India. She completed her doctoral research on host-pathogen interactions from Bose Institute, India, and received her PhD degree from Jadavpur University, India. Dr. Bhattacharyya obtained her postdoctoral research training in Gastroenterology from the Department of Medicine, University of Virginia, USA. During her postdoctoral training she studied the role of AP Endonuclease 1 in gastric epithelial cell biology. She joined NISER in the year 2010 as an Assistant Professor in the School of Biological Sciences. She has established herself as a promising scientist in the field of H. pylori research and Cancer Biology. Her research team has identified role of Siah proteins in gastric cancer and is currently involved in identifying novel strategies to selectively kill metastatic gastric cancer cells. She is a member of many professional societies and serves as a referee of a number of high impact journals. Research Interest Dr. Asima Bhattacharyya's research interests include "Gastric epithelial cell biology, molecular events in gastric cancer progression and metastasis, cell signalling events, host-pathogen interactions". |  |
University Emergency Hospital Bucharest, Romania
| Biography Research Interest
|  |
Mahidol University, Thailand
| Biography Research Interest
|  |
Georgia State University, USA
| Biography Research Interest Drug delivery (via nanoparticles and liposomes) to the Liver (inflamed via cancer or fatty liver or fibrosis). |  |
Complejo Hospitalario Universitario de Vigo, Spain
| Biography Dr. Fabio Ausania, is an Hepato-pancreato-biliary Surgeon. He graduated from Campus Bio-Medico University of Rome (Italy) and he trained in HPB and Transplant Surgery at the Addenbrooke’s Hospital (Cambridge, UK) and at the Freeman Hospital (Newcastle upon Tyne, UK). He is currently HPB Surgery Consultant in the Complejo Hospitalario Universitario de Vigo (Spain). Research Interest
|  |
Joint Pathology Center, USA
| Biography Dr. Guanghua Wang graduated from Tianjin Medical University and received his postdoctoral training in molecular virology at the Fox Chase Cancer Center in Philadelphia, PA and the National Institutes of Health, Bethesda, MD. Dr Wang was also trained as a resident (2000-2004) in Clinical Pathology/Anatomic Pathology at New York University School of medicine and as a fellow in Gastrointestinal and Hepatic Pathology at the Armed Forces Institute of Pathology (AFIP), Washington DC. After fellowship training in GI/Hepatic pathology, Dr. Wang was pointed as a staff pathologist with the AFIP, and now is the chief of the Division of Molecular Pathology and a staff Pathologist in GI/Hepatic Pathology at the Joint Pathology Center in Bethesda, MD. Dr. Wang is board certified in Clinical Pathology/Anatomic Pathology and Molecular Genetic Pathology. Dr. Wang is a fellow of the College of American Pathologists and a member of Association of Molecular Pathology. Research Interest Dr. Wang’s current research interest includes areas of molecular pathology and gastrointestinal/hepatic pathology using molecular pathology techniques. |  |
King Fahad Specialist Hospital, Saudi Arabia
| Biography Dr. Abdul-Wahed N. Meshikhes did his 'A' level certificate of higher education in Worthing College of Technology, Worthing, West Sussex, England. He did his postgraduate surgical training in Manchester, England and obtained the fellowship of the Royal College of Surgeons in 1989. He worked as consultant surgeon and chairman of Surgery at Dammam Central hospital from 1991 till May 2005, when he joined King Fahad Specialist Hospital, Dammam as the chairman to establish the department of surgery. He is currently the head of general and minimally invasive surgery section. His research interest concentrates on surgery in sickle cell disease and hand assisted laparoscopic surgery. His current aim is to promote surgical research amongst trainee surgeons in the Middle East. He had authored many peer-reviewed articles which were published in many international journals. He is also in the editorial board of some international journals such as World Journal of Gastroenterology, World Journal of Surgical Procedures, ISN Minimally Invasive Surgery and Journal of Gastroenterology and Hepatology Research. Research Interest
|  |
University of Illinois at Chicago, USA
| Biography Dr. Alip Borthakur obtained his Ph.D in Biochemistryfrom University of Mysore, Mysore, India. He did his postdoctoral training from University of Illinois at Chicago, USA. He is currently serving as Assistant Professor, August 2009- present, Division of Gastroenterology & Hepatology, Department of Medicine, and University of Illinois at Chicago, USA. He was Involved in teaching the following courses during academic appointments as Assistant Professor (1984-1990) and Associate Professor (1991-2000) at the Assam Agricultural University, Jorhat, Assam, India. His work focuses on Probiotic interventions in gastroenterology. He has presented several works in international conferences and a member for many societies. Research Interest
| .png) |
University of Illinois College of Medicine at Peoria, USA
| Biography Dr. Kewei Wang received MD degree in 1984 and got a PhD degreein 1991. His expertise has been involving in the field of medical science to study the pathogenesis of human diseases, especially mechanisms of liver disease using cellular and molecular biology techniques. Hepatic apoptosis is a pivotal step in liver diseases. Ubiquitous apoptosisis implicated in a variety of pathological conditions such as liver dysfunction, fibrosis/cirrhosis, and tumorigenesis. Dysregulation of the hepatic apoptosis leads to a common road with different entrances. A series of publications were about apoptotic signaling pathways in hepatocytes, such as NFκb-survivin, C/EBPs-iNOS, Foxa2-cIAP1, and so on. These projects had successfully clarified some regulatory mechanisms of hepatic apoptosis. By examining these mechanisms through which components of the apoptotic machinery contribute to pathogenic processes, the understanding for liver injury-repair response is expanded. Hepatoprotective strategy can be designed via utilization of pro-/anti-apoptotic modalities in future. The long term goal is to identify therapeutic targets for the treatment of liver disease. Research Interest
|  |
GI Biopharma Inc , USA
| Biography Dr. Xiaofa Qin obtained his MD, PhD in Beijing Medial University, Beijing, China then became a lecturer and associate professor there. Later, he came to the United States and engaged in medical research as a postdoc, research instructor and assistant professor consecutively in Louisiana State University (LSU) Medical Center in Shreveport, University of Cincinnati college of Medicine, and University of Medicine and Dentistry of New Jersey (UMDNJ)/Rutgers (merged in 2013) - New Jersey Medical School. He brings forward a theory that impaired inactivation of pancreatic digestive proteases due to reduction of certain kinds of gut bacteria along with the improved hygiene and inhibition by some dietary chemicals may have played a critical role in inflammatory bowel disease (IBD, including ulcerative colitis and Crohn’s disease) and many other diseases emerged and dramatically increased in modern society, as the result of damage of gut barrier and increased infiltration of bacterial and dietary components. Recently, he founded GI Biopharma Inc aiming at developing some new treatments for these diseases. Research Interest The association among pancreatic proteases, gut microbiota, dietary chemicals, and diseases like inflammatory bowel disease ulcerative colitis and Crohn’s disease etc. |  |
Cincinnati Children Hospital Medical Center, USA
| Biography Dr. Alok Kumar Verma, PhD, is research fellow at Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children Hospital Medical Center, Cincinnati, Ohio, USA. Dr. Verma’s long-term research interest involves to understand the underlying immune mechanism of various immune cells in modulating the immune response.He has completed his initial PhD training at CSIR-Indian Institute of Toxicological Research.His doctoral research work was mainly focused to understand the mechanism involved in the allergenicity of food allergens using in vitro and in vivo model systems. Dr. Verma has identified seven IgE binding proteins which are responsible for chickpea induced allergy in sensitized individuals. Currently, he is working to explore the mechanistic aspects in steatohepatitis patients.Dr Verma is also member of several prestigious scientific societies such as The American Association of Immunologists (AAI), American Gastroenterological Association (AGA), European academy of allergy and clinical immunology (EAACI). Research Interest Involves to understand the underlying immune mechanism of various cells such as T cells, B cells, macrophages, mast cells, eosinophils and their released cytokines in modulating the provoked inflammatory responses in the body. 1. Allergenicity assessment of transgenic crops and exploring the mechanism behind allergic diseases. 2. Mechanistic aspects of steatohepatitis (Alcoholic and non- alcoholic steatohepatitis) |  |
